American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

SIGA Technologies Inc.

SIGA Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

SIGA historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of SIGA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
SIGA Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
SIGA Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
SIGA Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in SIGA holdings by institutional investors

Insider Trading

Quarterly net insider trading by SIGA's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $80,000 Aug 03, 2026 Issue: Budget/Appropriations
  • $140,000 Jul 17, 2026 Issue: Budget/Appropriations Health Issues
  • $80,000 May 04, 2026 Issue: Budget/Appropriations
  • $140,000 Apr 17, 2026 Issue: Budget/Appropriations Defense Health Issues
  • $80,000 Jan 21, 2026 Issue: Budget/Appropriations
  • $140,000 Jan 19, 2026 Issue: Budget/Appropriations Defense Health Issues
  • $140,000 Oct 20, 2025 Issue: Budget/Appropriations Defense Health Issues
  • $80,000 Oct 01, 2025 Issue: Budget/Appropriations
  • $140,000 Jul 17, 2025 Issue: Budget/Appropriations Defense Health Issues
  • $70,000 Jul 01, 2025 Issue: Budget/Appropriations
  • $50,000 May 05, 2025 Issue: Budget/Appropriations
  • $90,000 Apr 14, 2025 Issue: Budget/Appropriations Defense Health Issues
  • $60,000 Jan 17, 2025 Issue: Budget/Appropriations Defense Health Issues
  • $50,000 Jan 07, 2025 Issue: Budget/Appropriations
  • $60,000 Oct 21, 2024 Issue: Health Issues Defense Budget/Appropriations
  • $50,000 Oct 10, 2024 Issue: Budget/Appropriations
  • $50,000 Aug 01, 2024 Issue: Budget/Appropriations
  • $60,000 Jul 22, 2024 Issue: Health Issues Defense Budget/Appropriations
  • $50,000 Feb 05, 2024 Issue: Budget/Appropriations
  • $60,000 Jan 22, 2024 Issue: Health Issues Defense Budget/Appropriations
  • $50,000 Oct 31, 2023 Issue: Budget/Appropriations
  • $60,000 Oct 16, 2023 Issue: Health Issues Defense Budget/Appropriations
  • $60,000 Jul 20, 2023 Issue: Health Issues Defense Budget/Appropriations
  • $50,000 Jul 08, 2023 Issue: Budget/Appropriations
  • $60,000 Jan 20, 2023 Issue: Health Issues Defense Budget/Appropriations
  • $50,000 Jan 10, 2023 Issue: Budget/Appropriations
  • $60,000 Oct 19, 2022 Issue: Health Issues Defense Budget/Appropriations
  • $50,000 Oct 04, 2022 Issue: Budget/Appropriations
  • $60,000 Jul 20, 2022 Issue: Health Issues Defense Budget/Appropriations
  • $50,000 Jul 07, 2022 Issue: Budget/Appropriations
  • $60,000 Apr 19, 2022 Issue: Health Issues Defense Budget/Appropriations
  • $50,000 Apr 11, 2022 Issue: Budget/Appropriations
  • $60,000 Jan 20, 2022 Issue: Budget/Appropriations Health Issues Defense
  • $50,000 Jan 02, 2022 Issue: Budget/Appropriations
  • $50,000 Oct 20, 2021 Issue: Budget/Appropriations
  • $60,000 Oct 19, 2021 Issue: Budget/Appropriations Health Issues Defense
  • $60,000 Jul 16, 2021 Issue: Health Issues Budget/Appropriations Defense
  • $50,000 Jul 12, 2021 Issue: Budget/Appropriations
  • $60,000 Apr 20, 2021 Issue: Defense Health Issues Budget/Appropriations
  • $50,000 Apr 02, 2021 Issue: Budget/Appropriations
  • $50,000 Feb 17, 2021 Issue: Defense Budget/Appropriations Health Issues
  • $10,000 Jan 20, 2021 Issue: Budget/Appropriations
  • $30,000 Jan 04, 2021 Issue: Budget/Appropriations
  • $20,000 Nov 04, 2020 Issue: Budget/Appropriations
  • $20,000 Oct 20, 2020 Issue: Budget/Appropriations
  • $20,000 Jul 17, 2020 Issue: Budget/Appropriations
  • $20,000 Jul 06, 2020 Issue: Budget/Appropriations
  • $20,000 Apr 19, 2020 Issue: Budget/Appropriations
  • $20,000 Mar 30, 2020 Issue: Budget/Appropriations
  • $20,000 Jan 22, 2020 Issue: Budget/Appropriations
  • $20,000 Jan 03, 2020 Issue: Budget/Appropriations
  • $20,000 Oct 21, 2019 Issue: Budget/Appropriations
  • $20,000 Oct 01, 2019 Issue: Budget/Appropriations
  • $20,000 Jul 23, 2019 Issue: Budget/Appropriations
  • $20,000 Jul 08, 2019 Issue: Budget/Appropriations
  • $20,000 Apr 22, 2019 Issue: Budget/Appropriations
  • $20,000 Apr 01, 2019 Issue: Budget/Appropriations
  • $20,000 Jan 20, 2019 Issue: Budget/Appropriations
  • $20,000 Jan 07, 2019 Issue: Budget/Appropriations
  • $20,000 Oct 19, 2018 Issue: Budget/Appropriations
  • $20,000 Oct 09, 2018 Issue: Budget/Appropriations
  • $20,000 Jul 19, 2018 Issue: Budget/Appropriations
  • $20,000 Jul 10, 2018 Issue: Budget/Appropriations
  • $20,000 Apr 20, 2018 Issue: Budget/Appropriations
  • $20,000 Apr 02, 2018 Issue: Budget/Appropriations
  • $20,000 Jan 18, 2018 Issue: Budget/Appropriations
  • $20,000 Jan 04, 2018 Issue: Budget/Appropriations
  • $20,000 Oct 17, 2017 Issue: Budget/Appropriations
  • $20,000 Oct 03, 2017 Issue: Budget/Appropriations
  • $20,000 Jul 20, 2017 Issue: Budget/Appropriations
  • $20,000 Jul 10, 2017 Issue: Budget/Appropriations
  • $20,000 Apr 20, 2017 Issue: Budget/Appropriations
  • $20,000 Apr 07, 2017 Issue: Budget/Appropriations
  • $20,000 Jan 23, 2017 Issue: Budget/Appropriations
  • $20,000 Jan 03, 2017 Issue: Budget/Appropriations Health Issues
  • $20,000 Oct 19, 2016 Issue: Budget/Appropriations
  • $20,000 Oct 06, 2016 Issue: Budget/Appropriations
  • $20,000 Jul 20, 2016 Issue: Budget/Appropriations
  • $20,000 Jul 01, 2016 Issue: Budget/Appropriations
  • $20,000 Apr 15, 2016 Issue: Budget/Appropriations
  • $20,000 Apr 05, 2016 Issue: Budget/Appropriations
  • $20,000 Jan 19, 2016 Issue: Budget/Appropriations
  • $20,000 Jan 19, 2016 Issue: Budget/Appropriations
  • $20,000 Oct 19, 2015 Issue: Budget/Appropriations
  • $20,000 Oct 19, 2015 Issue: Budget/Appropriations
  • $20,000 Jul 20, 2015 Issue: Budget/Appropriations
  • $20,000 Jul 15, 2015 Issue: Budget/Appropriations
  • $20,000 Apr 20, 2015 Issue: Budget/Appropriations
  • $20,000 Apr 03, 2015 Issue: Budget/Appropriations
  • $20,000 Jan 15, 2015 Issue: Health Issues
  • $20,000 Jan 05, 2015 Issue: Budget/Appropriations
  • $20,000 Oct 16, 2014 Issue: Health Issues
  • $20,000 Oct 07, 2014 Issue: Budget/Appropriations
  • $20,000 Jul 21, 2014 Issue: Budget/Appropriations
  • $20,000 Jul 15, 2014 Issue: Health Issues
  • $20,000 Apr 15, 2014 Issue: Budget/Appropriations
  • $20,000 Apr 14, 2014 Issue: Health Issues
  • $20,000 Jan 24, 2014 Issue: Budget/Appropriations
  • $20,000 Jan 15, 2014 Issue: Health Issues
  • $20,000 Oct 15, 2013 Issue: Health Issues
Revolving Door

Former government officials who have lobbied for SIGA

2 former government officials at 2 lobbying firms have lobbied for SIGA, most recently Aug 03, 2026.

  • Steven Crane House Subcommittee clerk, House Committee on Appropriations Formerly Subcommittee clerk, House Committee on Appropriations · CRANE STRATEGIES · Aug 03, 2026
  • Mark Mioduski House Prof Staff; House Approps Cmte (Obey) Formerly Prof Staff; House Approps Cmte (Obey) · CORNERSTONE GOVERNMENT AFFAIRS, INC. · Jan 21, 2021
Corporate Lobbying

SIGA Estimated quarterly lobbying spending

Revenue Breakdown

SIGA Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
SIGA Income Statement
SIGA Balance Sheet
SIGA Cash Flow
U.S. Patents

New SIGA patent grants

  • Patent Title: Polymorphic forms of st-246 and methods of preparation Oct. 07, 2025
  • Patent Title: Polymorphic forms of st-246 and methods of preparation Feb. 06, 2024
  • Patent Title: St-246 (tecovirimat monohydrate) suspension formulations Oct. 10, 2023
  • Patent Title: St-246 (tecovirimat monohydrate) suspension formulations Sep. 06, 2022
  • Patent Title: Polymorphic forms of st-246 and methods of preparation Mar. 02, 2021
  • Patent Title: St-246 liquid formulations and methods Dec. 15, 2020
  • Patent Title: Rehydration of micronized tecovirimat monohydrate Jul. 21, 2020
  • Patent Title: Methods of preparing tecovirimat May. 26, 2020
  • Patent Title: St-246 liquid formulations and methods Mar. 03, 2020
  • Patent Title: Polymorphic forms of st-246 and methods of preparation Sep. 10, 2019
  • Patent Title: Inhibitors and methods of inhibiting bacterial and viral pathogens May. 15, 2018
  • Patent Title: St-246 liquid formulations and methods Mar. 06, 2018
  • Patent Title: Amorphous tecovirimat preparation Feb. 13, 2018
  • Patent Title: Methods of preparing tecovirimat Jan. 09, 2018
  • Patent Title: Polymorphic forms of st-246 and methods of preparation Aug. 29, 2017
  • Patent Title: Amorphous tecovirimat preparation Jun. 06, 2017
  • Patent Title: Inhibitors and methods of inhibiting bacterial and viral pathogens Feb. 14, 2017
  • Patent Title: Methods of preparing tecovirimat Jan. 17, 2017
  • Patent Title: Antiviral drugs for treatment or prevention of dengue infection May. 31, 2016
  • Patent Title: Polymorphic forms of st-246 and methods of preparation May. 17, 2016
  • Patent Title: Thienopyridine derivatives for the treatment and prevention of dengue virus infections Apr. 05, 2016
  • Patent Title: St-246 liquid formulations Jan. 12, 2016
  • Patent Title: Inhibitors and methods of inhibiting bacterial and viral pathogens Jan. 12, 2016
  • Patent Title: Compounds, compositions and methods for treatment and prevention of Jun. 02, 2015
  • Patent Title: Small molecule inhibitors for the treatment or prevention of dengue virus infection May. 12, 2015
  • Patent Title: Treatment and prevention of dengue virus infections Mar. 31, 2015
  • Patent Title: Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases Aug. 12, 2014
  • Patent Title: Anti-arenaviral compounds Jul. 29, 2014
  • Patent Title: Antiviral drugs for treatment of Jun. 17, 2014
  • Patent Title: Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses Mar. 04, 2014
  • Patent Title: Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses Feb. 25, 2014
  • Patent Title: Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses Feb. 04, 2014
  • Patent Title: Anti-viral drugs for treatment of arenavirus infection Jan. 14, 2014
  • Patent Title: Antiviral drugs for treatment of arenavirus infection Jan. 07, 2014
  • Patent Title: Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases Sep. 10, 2013
  • Patent Title: Antiviral drugs for treatment or prevention of dengue infection Aug. 27, 2013
  • Patent Title: Anti-arenaviral compounds Aug. 27, 2013
  • Patent Title: Antiviral drugs for treatment of arenavirus infection Jul. 23, 2013
  • Patent Title: Antiviral drugs for treatment of arenavirus infection Jun. 11, 2013
  • Patent Title: Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses Apr. 02, 2013
  • Patent Title: Antiviral drugs for treatment of arenavirus infection Apr. 03, 2012
  • Patent Title: Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases Feb. 28, 2012
  • Patent Title: Anti-arenaviral compounds Jan. 31, 2012
  • Patent Title: Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases Oct. 18, 2011
  • Patent Title: Sulfonyl semicarbazides, carbonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses Aug. 09, 2011
  • Patent Title: Antiviral drugs for treatment of arenavirus infection Jul. 12, 2011
  • Patent Title: Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases Jun. 07, 2011
  • Patent Title: Antiviral drugs for treatment of arenavirus infection Jan. 18, 2011
  • Patent Title: Compounds, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases Jun. 15, 2010
  • Patent Title: Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases Mar. 30, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to SIGA from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
SIGA News

Recent insights relating to SIGA

CNBC Recommendations

Recent picks made for SIGA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in SIGA

SIGA Analyst Ratings

SIGA Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
SIGA Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $SIGA stock a Buy, Sell, or Hold?

  • What is the price target for $SIGA stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

SIGA Top Shareholders
Shareholder
Shares Held
SIGA Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $SIGA stock?

  • Who owns the most shares of $SIGA stock?

  • What funds own $SIGA stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

SIGA Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view SIGA Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About SIGA

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

  • Address New York, NY
  • Market Cap 247.9 million
  • Employees 49
  • Industrial Classification Pharmaceutical Preparations

SIGA Technologies Inc. (SIGA) Historical Stock Prices

SIGA Technologies Inc. (SIGA) closed at $3.45 on September 25, 2026. Over the past year its adjusted close ranged from $2.87 to $8.15. Daily prices go back to January 2, 2014, 2,929 trading days in all.

  • 1 month+12.38%
  • 3 months-11.99%
  • Year to date-36.05%
  • 1 year-55.50%
  • 3 years-7.90%
  • 5 years-23.49%
  • Max+3.92%
See every congressional and insider trade on the SIGA price chart

Quiver Premium charts SIGA's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 25, 2026 3.26 3.52 3.23 3.45 3.45 1,165,760
Sep 24, 2026 3.17 3.27 3.15 3.25 3.25 1,118,431
Sep 23, 2026 3.25 3.27 3.13 3.17 3.17 435,190
Sep 22, 2026 3.19 3.31 3.15 3.26 3.26 493,595
Sep 21, 2026 3.13 3.17 3.08 3.16 3.16 471,186
Sep 18, 2026 3.03 3.20 3.00 3.14 3.14 746,251
Sep 17, 2026 3.09 3.13 3.04 3.05 3.05 711,059
Sep 16, 2026 2.98 3.10 2.93 3.10 3.10 811,869
Sep 15, 2026 3.14 3.14 2.94 2.98 2.98 480,092
Sep 14, 2026 3.04 3.15 2.99 3.15 3.15 522,908
Sep 11, 2026 3.06 3.08 3.01 3.03 3.03 453,372
Sep 10, 2026 3.07 3.07 3.00 3.02 3.02 550,419
Sep 9, 2026 3.20 3.25 3.04 3.08 3.08 582,774
Sep 8, 2026 3.25 3.27 3.14 3.20 3.20 786,127
Sep 4, 2026 3.20 3.32 3.10 3.29 3.29 899,427
Sep 3, 2026 3.22 3.28 3.15 3.23 3.23 830,215
Sep 2, 2026 3.24 3.26 3.18 3.21 3.21 663,248
Sep 1, 2026 3.13 3.27 3.10 3.24 3.24 1,077,115
Aug 31, 2026 3.06 3.15 3.00 3.14 3.14 889,211
Aug 28, 2026 3.08 3.08 2.98 3.06 3.06 569,084
Aug 27, 2026 3.05 3.08 2.91 3.06 3.06 813,649
Aug 26, 2026 3.06 3.11 3.00 3.07 3.07 651,123
Aug 25, 2026 2.96 3.05 2.96 3.04 3.04 375,047
Aug 24, 2026 3.08 3.12 2.92 2.94 2.94 667,090
Aug 21, 2026 2.99 3.09 2.95 3.04 3.04 1,535,996
Aug 20, 2026 3.10 3.10 2.93 2.97 2.97 582,591
Aug 19, 2026 2.99 3.12 2.97 3.11 3.11 898,452
Aug 18, 2026 2.92 3.00 2.88 2.99 2.99 457,038
Aug 17, 2026 3.00 3.00 2.88 2.93 2.93 766,757
Aug 14, 2026 2.89 3.01 2.85 3.00 3.00 588,162
Aug 13, 2026 2.89 2.94 2.85 2.88 2.88 479,913
Aug 12, 2026 2.87 2.92 2.83 2.87 2.87 636,597
Aug 11, 2026 2.93 2.99 2.87 2.88 2.88 582,334
Aug 10, 2026 3.07 3.08 2.86 2.93 2.93 1,019,763
Aug 7, 2026 3.15 3.19 3.04 3.05 3.05 678,828
Aug 6, 2026 3.15 3.19 3.10 3.12 3.12 493,549
Aug 5, 2026 3.24 3.24 3.11 3.15 3.15 418,103
Aug 4, 2026 3.20 3.29 3.19 3.24 3.24 468,236
Aug 3, 2026 3.31 3.31 3.17 3.21 3.21 515,535
Jul 31, 2026 3.25 3.32 3.15 3.27 3.27 661,031
Jul 30, 2026 3.33 3.33 3.21 3.25 3.25 431,697
Jul 29, 2026 3.33 3.43 3.29 3.34 3.34 1,012,254
Jul 28, 2026 3.11 3.34 3.01 3.34 3.34 1,176,213
Jul 27, 2026 3.13 3.21 3.02 3.10 3.10 3,966,473
Jul 24, 2026 3.14 3.17 3.03 3.11 3.11 877,473
Jul 23, 2026 3.35 3.37 3.10 3.15 3.15 1,137,242
Jul 22, 2026 3.57 3.59 3.36 3.39 3.39 471,128
Jul 21, 2026 3.48 3.61 3.44 3.58 3.58 463,172
Jul 20, 2026 3.46 3.49 3.40 3.48 3.48 381,826
Jul 17, 2026 3.53 3.55 3.44 3.44 3.44 328,782
Jul 16, 2026 3.57 3.67 3.51 3.56 3.56 675,451
Jul 15, 2026 3.42 3.57 3.41 3.56 3.56 535,552
Jul 14, 2026 3.61 3.62 3.42 3.42 3.42 456,343
Jul 13, 2026 3.59 3.71 3.59 3.61 3.61 562,470
Jul 10, 2026 3.52 3.61 3.49 3.59 3.59 627,493
Jul 9, 2026 3.56 3.59 3.42 3.50 3.50 660,117
Jul 8, 2026 3.66 3.66 3.50 3.54 3.54 588,656
Jul 7, 2026 3.78 3.81 3.63 3.67 3.67 580,205
Jul 6, 2026 3.89 3.90 3.74 3.75 3.75 489,092
Jul 2, 2026 3.75 3.94 3.75 3.86 3.86 545,662
Jul 1, 2026 3.64 3.82 3.64 3.72 3.72 741,432
Jun 30, 2026 3.62 3.75 3.56 3.64 3.64 1,099,486
Jun 29, 2026 3.94 3.95 3.56 3.61 3.61 1,263,158
Jun 26, 2026 3.90 4.04 3.82 3.92 3.92 1,986,649
Jun 25, 2026 4.32 4.35 3.88 3.95 3.95 818,629
Jun 24, 2026 4.32 4.40 4.31 4.32 4.32 415,920
Jun 23, 2026 4.33 4.39 4.29 4.30 4.30 278,584
Jun 22, 2026 4.32 4.41 4.32 4.33 4.33 369,522
Jun 18, 2026 4.36 4.37 4.28 4.32 4.32 595,075
Jun 17, 2026 4.32 4.36 4.25 4.31 4.31 504,165
Jun 16, 2026 4.33 4.34 4.28 4.30 4.30 347,358
Jun 15, 2026 4.35 4.37 4.29 4.34 4.34 291,462
Jun 12, 2026 4.32 4.36 4.30 4.32 4.32 226,562
Jun 11, 2026 4.32 4.37 4.25 4.31 4.31 411,747
Jun 10, 2026 4.35 4.42 4.34 4.36 4.36 294,358
Jun 9, 2026 4.37 4.44 4.34 4.39 4.39 375,592
Jun 8, 2026 4.32 4.38 4.28 4.33 4.33 353,472
Jun 5, 2026 4.43 4.45 4.29 4.30 4.30 551,038
Jun 4, 2026 4.35 4.45 4.35 4.43 4.43 352,705
Jun 3, 2026 4.34 4.34 4.24 4.29 4.29 327,589
Jun 2, 2026 4.44 4.46 4.28 4.32 4.32 454,008
Jun 1, 2026 4.61 4.62 4.42 4.44 4.44 380,001
May 29, 2026 4.76 4.79 4.66 4.68 4.68 416,991
May 28, 2026 4.73 4.77 4.67 4.76 4.76 317,089
May 27, 2026 4.68 4.76 4.68 4.73 4.73 286,793
May 26, 2026 4.72 4.75 4.66 4.67 4.67 313,544
May 22, 2026 4.68 4.80 4.65 4.68 4.68 602,726
May 21, 2026 4.47 4.71 4.39 4.71 4.71 856,136
May 20, 2026 4.37 4.62 4.36 4.49 4.49 1,007,539
May 19, 2026 4.25 4.38 4.20 4.37 4.37 488,228
May 18, 2026 4.20 4.30 4.17 4.27 4.27 599,018
May 15, 2026 4.22 4.31 4.09 4.17 4.17 700,383
May 14, 2026 4.31 4.38 4.25 4.26 4.26 445,099
May 13, 2026 4.42 4.47 4.30 4.31 4.31 512,414
May 12, 2026 4.55 4.57 4.31 4.45 4.45 629,640
May 11, 2026 4.84 4.92 4.54 4.55 4.55 498,795
May 8, 2026 4.64 4.81 4.40 4.80 4.80 1,083,743
May 7, 2026 4.75 4.87 4.71 4.73 4.73 615,251
May 6, 2026 4.67 4.76 4.67 4.70 4.70 426,459
May 5, 2026 4.64 4.71 4.61 4.64 4.64 366,918
May 4, 2026 4.58 4.70 4.58 4.63 4.63 343,208
May 1, 2026 4.57 4.67 4.57 4.60 4.60 381,074
Apr 30, 2026 4.51 4.67 4.50 4.60 4.60 394,543
Apr 29, 2026 4.56 4.56 4.49 4.53 4.53 370,914
Apr 28, 2026 4.56 4.61 4.54 4.59 4.59 277,038
Apr 27, 2026 4.55 4.66 4.54 4.56 4.56 419,577
Apr 24, 2026 4.53 4.67 4.51 4.57 4.57 453,615
Apr 23, 2026 4.51 4.55 4.45 4.53 4.53 365,213
Apr 22, 2026 4.44 4.54 4.44 4.51 4.51 448,040
Apr 21, 2026 4.57 4.59 4.42 4.44 4.44 391,774
Apr 20, 2026 4.72 4.72 4.57 4.57 4.57 361,846
Apr 17, 2026 4.74 4.80 4.68 4.76 4.76 573,181
Apr 16, 2026 4.68 4.69 4.56 4.64 4.64 474,167
Apr 15, 2026 4.57 4.70 4.52 4.70 4.70 567,478
Apr 14, 2026 4.40 4.62 4.36 4.58 4.58 410,366
Apr 13, 2026 4.33 4.46 4.29 4.46 4.46 805,747
Apr 10, 2026 4.47 4.47 4.33 4.36 4.36 753,025
Apr 9, 2026 4.56 4.59 4.35 4.40 4.40 685,967
Apr 8, 2026 4.65 4.68 4.56 4.58 4.58 1,168,405
Apr 7, 2026$0.6 dividend 4.60 4.63 4.46 4.53 4.53 975,466
Apr 6, 2026 5.25 5.31 5.07 5.20 4.59 1,032,388
Apr 2, 2026 5.10 5.25 5.10 5.24 4.63 872,456
Apr 1, 2026 5.40 5.45 5.08 5.17 4.57 1,751,124
Mar 31, 2026 5.28 5.36 5.20 5.35 4.72 986,350
Mar 30, 2026 5.30 5.32 5.20 5.26 4.64 623,017
Mar 27, 2026 5.33 5.44 5.19 5.30 4.68 1,341,564
Mar 26, 2026 4.93 5.04 4.89 4.96 4.38 705,315
Mar 25, 2026 5.08 5.10 4.96 4.99 4.41 446,650
Mar 24, 2026 4.92 5.01 4.92 5.00 4.42 813,787
Mar 23, 2026 5.06 5.06 4.86 4.99 4.41 793,100
Mar 20, 2026 5.07 5.08 4.87 4.94 4.36 1,105,044
Mar 19, 2026 4.91 5.11 4.83 5.08 4.49 906,128
Mar 18, 2026 5.01 5.01 4.81 4.86 4.29 1,073,031
Mar 17, 2026 5.44 5.47 5.01 5.02 4.43 1,006,838
Mar 16, 2026 5.34 5.49 5.32 5.46 4.82 616,601
Mar 13, 2026 5.46 5.52 5.12 5.26 4.64 783,284
Mar 12, 2026 5.37 5.58 5.37 5.47 4.83 700,338
Mar 11, 2026 5.65 5.79 5.11 5.47 4.83 766,575
Mar 10, 2026 5.60 5.67 5.44 5.65 4.99 933,688
Mar 9, 2026 5.71 5.71 5.45 5.60 4.95 1,096,570
Mar 6, 2026 6.14 6.16 5.78 5.80 5.12 778,611
Mar 5, 2026 6.27 6.50 6.23 6.24 5.51 734,894
Mar 4, 2026 6.28 6.37 6.22 6.37 5.62 701,903
Mar 3, 2026 6.41 6.41 6.16 6.22 5.49 509,817
Mar 2, 2026 6.40 6.64 6.33 6.55 5.78 464,563
Feb 27, 2026 6.55 6.58 6.37 6.47 5.71 1,317,060
Feb 26, 2026 6.85 6.85 6.59 6.64 5.86 348,614
Feb 25, 2026 6.81 6.86 6.71 6.80 6.00 325,368
Feb 24, 2026 6.73 6.91 6.73 6.76 5.97 311,321
Feb 23, 2026 6.75 6.86 6.55 6.71 5.92 300,312
Feb 20, 2026 6.74 6.83 6.63 6.75 5.96 1,058,752
Feb 19, 2026 6.67 6.78 6.54 6.77 5.98 418,895
Feb 18, 2026 6.75 6.84 6.67 6.68 5.90 312,360
Feb 17, 2026 6.79 6.90 6.68 6.78 5.99 252,633
Feb 13, 2026 6.68 7.02 6.68 6.79 6.00 314,019
Feb 12, 2026 6.67 6.69 6.56 6.68 5.90 312,074
Feb 11, 2026 6.70 6.76 6.51 6.64 5.86 502,288
Feb 10, 2026 6.54 6.83 6.54 6.69 5.91 353,852
Feb 9, 2026 6.69 6.69 6.47 6.53 5.77 237,063
Feb 6, 2026 6.55 6.77 6.55 6.70 5.92 395,862
Feb 5, 2026 6.63 6.77 6.50 6.51 5.75 327,531
Feb 4, 2026 7.00 7.03 6.61 6.73 5.94 405,704
Feb 3, 2026 6.95 7.11 6.87 6.95 6.14 356,574
Feb 2, 2026 6.68 7.00 6.62 6.95 6.14 529,852
Jan 30, 2026 6.77 6.80 6.60 6.70 5.92 313,082
Jan 29, 2026 6.70 6.83 6.58 6.81 6.01 279,397
Jan 28, 2026 6.85 6.85 6.66 6.67 5.89 234,281
Jan 27, 2026 6.76 6.87 6.70 6.82 6.02 322,812
Jan 26, 2026 6.65 6.84 6.65 6.79 6.00 388,006
Jan 23, 2026 6.72 6.76 6.62 6.64 5.86 274,334
Jan 22, 2026 6.68 6.81 6.63 6.73 5.94 351,448
Jan 21, 2026 6.54 6.67 6.42 6.66 5.88 234,037
Jan 20, 2026 6.50 6.61 6.41 6.54 5.78 433,399
Jan 16, 2026 6.61 6.77 6.57 6.58 5.81 313,260
Jan 15, 2026 6.72 6.72 6.54 6.61 5.84 329,084
Jan 14, 2026 6.61 6.76 6.52 6.72 5.93 249,991
Jan 13, 2026 6.60 6.63 6.45 6.60 5.83 253,515
Jan 12, 2026 6.65 6.79 6.56 6.59 5.82 450,510
Jan 9, 2026 6.78 6.82 6.60 6.61 5.84 280,975
Jan 8, 2026 6.80 6.85 6.67 6.77 5.98 304,425
Jan 7, 2026 6.75 6.88 6.68 6.85 6.05 454,936
Jan 6, 2026 6.39 6.71 6.28 6.66 5.88 463,718
Jan 5, 2026 6.29 6.50 6.28 6.39 5.64 539,994
Jan 2, 2026 6.17 6.33 6.11 6.27 5.54 388,123
Dec 31, 2025 6.16 6.21 6.08 6.11 5.39 312,755
Dec 30, 2025 6.25 6.30 6.14 6.17 5.45 314,831
Dec 29, 2025 6.25 6.33 6.21 6.25 5.52 271,331
Dec 26, 2025 6.27 6.33 6.21 6.27 5.54 318,507
Dec 24, 2025 6.21 6.32 6.20 6.27 5.54 182,528
Dec 23, 2025 6.23 6.34 6.21 6.23 5.50 461,926
Dec 22, 2025 6.26 6.34 6.20 6.25 5.52 295,852
Dec 19, 2025 6.28 6.41 6.25 6.27 5.54 529,905
Dec 18, 2025 6.36 6.45 6.29 6.31 5.57 344,290
Dec 17, 2025 6.29 6.39 6.27 6.38 5.63 219,639
Dec 16, 2025 6.28 6.33 6.21 6.28 5.54 274,417
Dec 15, 2025 6.47 6.54 6.28 6.32 5.58 348,537
Dec 12, 2025 6.51 6.52 6.39 6.46 5.70 296,176
Dec 11, 2025 6.30 6.54 6.25 6.52 5.76 462,103
Dec 10, 2025 6.25 6.36 6.20 6.25 5.52 640,350
Dec 9, 2025 6.15 6.37 6.15 6.25 5.52 364,472
Dec 8, 2025 6.24 6.29 6.13 6.15 5.43 252,992
Dec 5, 2025 6.34 6.35 6.17 6.20 5.47 236,540
Dec 4, 2025 6.29 6.35 6.15 6.34 5.60 304,732
Dec 3, 2025 5.93 6.26 5.93 6.24 5.51 322,389
Dec 2, 2025 5.93 6.11 5.90 5.93 5.24 347,839
Dec 1, 2025 6.02 6.06 5.85 5.89 5.20 309,593
Nov 28, 2025 6.09 6.15 6.00 6.06 5.35 179,674
Nov 26, 2025 6.00 6.05 5.90 6.04 5.33 229,444
Nov 25, 2025 5.94 6.10 5.83 5.95 5.25 556,703
Nov 24, 2025 5.85 6.00 5.83 5.94 5.25 356,199
Nov 21, 2025 5.73 5.97 5.71 5.84 5.16 342,459
Nov 20, 2025 5.96 6.05 5.75 5.77 5.09 455,739
Nov 19, 2025 5.95 5.99 5.84 5.91 5.22 360,050
Nov 18, 2025 5.85 6.02 5.80 5.97 5.27 430,561
Nov 17, 2025 6.01 6.08 5.85 5.90 5.21 505,797
Nov 14, 2025 6.01 6.11 5.85 6.00 5.30 543,900
Nov 13, 2025 6.20 6.33 5.95 6.08 5.37 784,262
Nov 12, 2025 6.36 6.41 6.20 6.21 5.48 453,671
Nov 11, 2025 6.52 6.56 6.25 6.29 5.55 557,125
Nov 10, 2025 6.47 6.63 6.20 6.51 5.75 815,116
Nov 7, 2025 7.30 7.43 6.50 6.54 5.78 1,008,654
Nov 6, 2025 8.41 8.46 8.15 8.17 7.21 326,143
Nov 5, 2025 8.14 8.46 8.07 8.43 7.44 315,771
Nov 4, 2025 8.00 8.19 7.90 8.14 7.19 329,812
Nov 3, 2025 8.28 8.29 8.06 8.20 7.24 439,598
Oct 31, 2025 8.27 8.35 8.08 8.28 7.31 362,569
Oct 30, 2025 8.13 8.31 8.06 8.31 7.34 337,416
Oct 29, 2025 8.45 8.45 8.07 8.13 7.18 348,972
Oct 28, 2025 8.43 8.54 8.37 8.44 7.45 313,881
Oct 27, 2025 8.50 8.54 8.41 8.43 7.44 297,776
Oct 24, 2025 8.46 8.52 8.33 8.44 7.45 196,651
Oct 23, 2025 8.26 8.47 8.11 8.40 7.42 271,025
Oct 22, 2025 8.42 8.54 8.06 8.26 7.29 301,581
Oct 21, 2025 8.48 8.48 8.32 8.47 7.48 266,660
Oct 20, 2025 8.40 8.54 8.36 8.48 7.49 349,595
Oct 17, 2025 8.27 8.41 8.22 8.30 7.33 281,858
Oct 16, 2025 8.43 8.53 8.23 8.35 7.37 567,513
Oct 15, 2025 8.25 8.43 8.20 8.42 7.43 268,196
Oct 14, 2025 8.15 8.27 7.94 8.19 7.23 355,233
Oct 13, 2025 8.37 8.44 8.20 8.26 7.29 291,696
Oct 10, 2025 8.45 8.47 8.20 8.22 7.26 293,254
Oct 9, 2025 8.30 8.46 8.28 8.45 7.46 242,441
Oct 8, 2025 8.49 8.54 8.25 8.28 7.31 303,719
Oct 7, 2025 8.19 8.56 8.15 8.44 7.45 517,132
Oct 6, 2025 8.95 8.95 8.21 8.23 7.27 645,278
Oct 3, 2025 9.04 9.17 8.90 8.95 7.90 422,380
Oct 2, 2025 9.25 9.25 8.90 8.95 7.90 456,358
Oct 1, 2025 9.07 9.29 8.89 9.23 8.15 592,400
Sep 30, 2025 8.96 9.18 8.96 9.15 8.08 472,176
Sep 29, 2025 9.16 9.22 8.92 8.96 7.91 418,424
Sep 26, 2025 8.87 9.17 8.84 9.16 8.09 516,547
Sep 25, 2025 8.83 8.92 8.72 8.78 7.75 253,141

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
SIGA Technologies Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at SIGA, per a recent SEC DEF 14A filing. We estimate that the median employee at SIGA TECHNOLOGIES INC is paid $163,709.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation